Intermittent fasting reduces inflammatory markers in several autoimmune conditions. The evidence is real, and for rheumatoid arthritis in particular, it is substantial. But fasting is not universally safe for autoimmune patients, and the type of IF protocol matters as much as whether you fast at all.
This guide covers five IF protocols, the immunological mechanisms behind them, condition-by-condition evidence (graded A through C), and clear contraindications. If you have been considering fasting alongside your current treatment, what follows is the clinical picture stripped of hype.
What Is Intermittent Fasting? (Types Explained)
Intermittent fasting describes eating patterns organized around time restriction or periodic caloric reduction. It is not starvation. It is not caloric restriction in the traditional sense. The distinction matters for autoimmune patients because the timing of fasting triggers specific biological processes (autophagy, immune cell turnover) that continuous caloric restriction does not.
16:8 (Time-Restricted Eating)
Sixteen hours of fasting, eight hours of eating. Most people achieve this by skipping breakfast and eating between noon and 8 PM.
This is the most studied IF protocol for inflammatory markers and the most practical entry point. Moro et al. (2016) demonstrated significant reductions in IL-6 and TNF-alpha in subjects following 16:8 for eight weeks. Adherence is high because the adjustment is modest: you are already fasting during sleep.
5:2 Protocol
Five normal eating days per week, two non-consecutive days at 500 to 600 calories. The caloric restriction days are enough to shift inflammatory signaling without the sustained stress of daily fasting.
Ramadan fasting follows a roughly similar intermittent rhythm, which is why Ramadan cohort studies are relevant to 5:2 evidence. More on that below.
OMAD (One Meal a Day)
A 23:1 fasting window. One meal, consumed within roughly sixty minutes.
OMAD has limited autoimmune-specific research. The physiological stress is considerably higher than 16:8, and the risk of inadequate nutrient intake is real for autoimmune patients already prone to deficiencies. This is not a recommended starting point.
Extended Water Fasting (24 to 72+ Hours)
Extended fasts trigger deep autophagy and mTOR suppression. They also trigger significant metabolic stress.
For autoimmune patients, extended water fasting should be medically supervised. It is contraindicated for many (see the safety section below). The classical RA fasting studies used supervised fasts of this duration, but they were conducted in clinical settings with physician oversight.
Ramadan Fasting: A Natural Human Experiment
Ramadan provides the largest natural cohort of intermittent fasters: complete abstinence from food and water from dawn to sunset (roughly 14 to 18 hours depending on latitude and season) for 30 days. Multiple studies have tracked RA, MS, and IBD patients during Ramadan.
The data is valuable but comes with an important caveat. Ramadan fasting includes water restriction, which changes the physiology compared to standard IF where water, tea, and coffee are permitted during the fasting window. Results are not directly translatable to 16:8 protocols.
How IF Differs From the Fasting Mimicking Diet
Standard IF restricts when you eat. The fasting mimicking diet restricts what and how much you eat over five consecutive days (700 to 1,100 calories per day, plant-based, low protein, specific macronutrient ratios).
FMD was engineered by Valter Longo's lab to trigger the deepest fasting biology (immune cell recycling, stem cell activation) while still providing calories. The two approaches are complementary, not competing. Many autoimmune patients use daily 16:8 as a baseline practice, with one FMD cycle quarterly for deeper immune modulation.
| Protocol | Fasting Window | Eating Window | Autophagy | Best Evidence For | Risk Level |
|---|---|---|---|---|---|
| 16:8 (TRE) | 16 hours daily | 8 hours | Moderate | RA, general inflammation | Low |
| 5:2 Protocol | 2 days/week (500–600 kcal) | 5 normal days | Moderate | RA, metabolic inflammation | Low–Moderate |
| OMAD (23:1) | 23 hours daily | 1 hour | Moderate–High | Limited autoimmune data | Moderate |
| Extended (24–72h) | 24–72+ hours | Refeeding after fast | High | RA (classical studies) | High (supervised only) |
| FMD (5-day) | 5 consecutive days | 700–1,100 kcal/day, specific macros | Very High (engineered) | MS pilot, Crohn's RCT | Moderate |
Evidence grades: A = multiple RCTs/meta-analyses; B = single RCT, strong mechanistic + clinical; C = preliminary/mechanistic only.
How Fasting Affects the Immune System
Five mechanisms connect fasting to autoimmune disease. Two have solid human evidence. Three remain primarily mechanistic.
Reduction in Pro-Inflammatory Cytokines (Grade B)
Fasting reduces IL-6, TNF-alpha, and IL-17, three cytokines that drive inflammation in RA, IBD, psoriasis, and lupus. This is the best-established effect in humans.
Ramadan studies in RA patients consistently show reduced CRP and IL-6 during the fasting month. Moro et al. (2016) found similar reductions with 16:8 time-restricted eating over eight weeks in otherwise healthy subjects. The effect is reproducible and dose-dependent: longer fasting windows produce larger cytokine reductions.
Autophagy Induction (Grade B)
After roughly 16 to 18 hours without food, cells upregulate autophagy: a self-cleaning process that removes damaged proteins and dysfunctional mitochondria. Alirezaei et al. (2010) confirmed increased autophagy markers in human muscle biopsies during short-term fasting.
For autoimmune disease, autophagy is relevant because clearance of damaged cells reduces the pool of autoantigens (self-proteins that confused immune cells attack). Animal models show autophagy reduces severity in lupus-like nephritis and experimental colitis.
Gut Microbiome Remodeling (Grade B)
Time-restricted eating restructures the circadian cycling of gut bacteria. Liang et al. (2022) found that TRE shifts gut microbiome composition toward anti-inflammatory species, specifically Akkermansia muciniphila and Faecalibacterium prausnitzii, both of which are depleted in multiple autoimmune conditions.
This matters because the gut-immune axis is central to autoimmune pathology. Fasano's work on zonulin and intestinal permeability established that gut barrier dysfunction precedes autoimmune onset in genetically susceptible individuals. A microbiome that favors barrier integrity is protective.
The effect requires sustained practice. When the eating window expands back to unrestricted hours, the microbial composition reverts.
Regulatory T Cell Upregulation (Grade C)
Fasting promotes a shift from Th17 cells (pro-inflammatory, implicated in RA, psoriasis, and MS) to Tregs (regulatory cells that suppress autoimmune responses). This is demonstrated in animal models of autoimmune disease.
Human data confirming this shift during IF is limited. The mechanism is plausible and consistent with the cytokine reductions observed in human studies, but Grade C is the honest assessment.
mTOR Suppression and Immune Cell Recycling (Grade C)
The mTOR pathway is overactive in several autoimmune conditions, including lupus. Pharmaceutical mTOR inhibitors (rapamycin) are studied in SLE for this reason. Fasting achieves partial mTOR suppression through nutrient deprivation.
The fasting mimicking diet produces deeper mTOR suppression than daily IF because the caloric restriction is more severe and sustained over five days. Animal data is strong. Human clinical data specific to mTOR modulation through IF in autoimmune patients is sparse.
Intermittent Fasting by Condition: What the Evidence Shows
Rheumatoid Arthritis: Strongest Human Evidence (Grade B)
RA has the most clinical data supporting fasting as an adjunct intervention.
Ramadan fasting studies consistently show reduced DAS-28 scores (the standard RA disease activity measure) during the fasting month. CRP and IL-6 drop measurably. Hafström et al. (1988) published the classical finding: short-term fasting produced significant RA symptom reduction. The catch was that symptoms rebounded after subjects returned to their normal diet.
Sköldstam et al. resolved this partially by demonstrating that fasting followed by a vegetarian anti-inflammatory diet maintained the improvement. The implication is clear: fasting alone is not enough. Dietary quality during the eating window determines whether benefits persist.
Practical recommendation: 16:8 or 5:2 as an adjunct to anti-inflammatory eating. If you take high-dose methotrexate, discuss timing with your rheumatologist, as fasting can increase methotrexate-related nausea.
Multiple Sclerosis: Promising but Limited (Grade B for FMD, Grade C for IF)
The strongest MS fasting evidence comes from the fasting mimicking diet, not standard IF. Choi et al. (2016, Cell Reports) showed that FMD cycles in a mouse model of MS reduced autoimmune demyelination and promoted remyelination. A small human pilot arm in the same study confirmed FMD was safe in MS patients and showed some inflammatory marker improvement, though it was not powered for efficacy.
Standard IF in MS has limited dedicated trial data. Fitzgerald et al. (2018) found that Mediterranean diet combined with caloric restriction improved fatigue in MS patients, which overlaps with IF principles but is not IF specifically.
For MS patients considering fasting, FMD protocols have stronger support than daily time-restricted eating.
Inflammatory Bowel Disease: Proceed with Caution (Grade B/C)
IBD and fasting have a complicated relationship. Tong et al. (2023) published a systematic review finding that time-restricted eating reduced inflammatory markers in IBD, but outcomes were heterogeneous. Some Ramadan studies show improvement in mild UC. Others report flare induction.
The core problem: IBD patients frequently have malabsorption and nutrient deficiencies. Extended fasting windows exacerbate both. For patients with active Crohn's, stricturing disease, or low BMI, fasting is not recommended.
The best evidence supports 16:8 for mild UC in remission. For Crohn's specifically, evidence-graded supplements have a stronger evidence base than fasting protocols.
Hashimoto's Thyroiditis: Caution Warranted (Grade C)
No published RCTs have tested IF specifically in Hashimoto's patients. The limited data that exists raises more concerns than it resolves.
Three factors make aggressive IF risky for Hashimoto's. First, HPA axis dysregulation is common in Hashimoto's; fasting adds cortisol stress to an already strained system. Second, low T3 (frequent in Hashimoto's) impairs metabolic adaptation to fasting. Some patients feel dramatically worse. Third, aggressive caloric restriction can suppress TSH on lab work, masking thyroid dysfunction.
A gentler approach may work: 12:12 circadian-aligned eating (finish dinner by 7 PM, eat breakfast at 7 AM). This aligns with natural cortisol rhythms without the metabolic stress of a 16-hour fast. If you have Hashimoto's, check TSH, Free T3, ferritin, and cortisol before attempting any IF protocol, and recheck at 90 days.
For Hashimoto's-specific interventions with stronger evidence, selenium, myo-inositol, and vitamin D have dedicated RCT data that fasting lacks.
Lupus (SLE): Theoretical Benefit, Limited Data (Grade C)
mTOR pathway dysregulation is documented in SLE, and fasting suppresses mTOR. The logic is sound. The clinical evidence is not there yet.
No dedicated IF + SLE RCTs exist. Small observational reports suggest caloric restriction may reduce disease activity markers, but lupus patients often have kidney involvement (lupus nephritis) where very low caloric intake can be harmful. Fatigue and adrenal involvement make fasting harder to tolerate.
If attempting IF with lupus: 16:8 only, during remission, with physician oversight. Supplements with stronger lupus evidence (vitamin D, omega-3, NAC) should take priority.
Psoriasis: Emerging Evidence (Grade B)
Psoriasis responds to caloric restriction through a metabolic pathway. Visceral fat drives IL-17 and TNF-alpha production, both central to psoriatic inflammation. Reducing visceral fat reduces the inflammatory signal.
Castaldo et al. (2020) showed that a very-low-calorie ketogenic diet improved PASI scores (the psoriasis severity measure) significantly. This overlaps with fasting physiology because both achieve ketosis and reduce visceral adiposity. Hypocaloric diets are consistently associated with psoriasis improvement in overweight patients.
The best candidates for IF among psoriasis patients are those who are overweight or obese. 16:8 or 5:2 combined with an anti-inflammatory diet targets the metabolic root of psoriatic inflammation directly.
Sjögren's Syndrome: No Dedicated Data
No IF-specific Sjögren's studies exist. The general anti-inflammatory mechanisms of fasting apply in theory, and the condition-specific interventions covered in our Sjögren's natural treatment guide have more supporting evidence.
One practical note: xerostomia (chronic dry mouth) makes prolonged fasting uncomfortable. Hydration during fasting hours is particularly important for Sjögren's patients.
How to Start Intermittent Fasting With an Autoimmune Disease
Step 1: Screen Yourself First
This step is not optional.
IF is not recommended if you have: BMI below 18.5, an active disease flare of any type, a history of eating disorders, adrenal insufficiency, severe anemia, Type 1 diabetes, or are pregnant or breastfeeding.
IF requires physician discussion first if you take methotrexate, biologics, prednisone above 10 mg/day, or thyroid medication.
Before starting, get baseline labs: fasting glucose, morning cortisol, ferritin, and a full thyroid panel. These become your comparison points at 90 days.
Step 2: Start With 12:12, Not 16:8
Autoimmune patients should not begin with aggressive protocols. Twelve hours fasting, twelve hours eating. Finish dinner by 7 PM, eat breakfast at 7 AM. This is circadian-aligned and imposes minimal metabolic stress.
Practice 12:12 for four weeks. Track energy, sleep quality, and symptom severity daily.
Step 3: Extend Gradually to 14:10, Then 16:8
Add one hour to the fasting window per week. Move from 12:12 to 13:11 to 14:10 over three weeks.
If energy drops or symptoms flare at any point, hold at the current window. For Hashimoto's patients, 14:10 may be the ceiling. Pushing to 16:8 when your thyroid cannot support the metabolic adaptation causes more harm than benefit.
Step 4: What to Eat in Your Eating Window
IF without dietary quality control has limited benefit for autoimmune disease. The eating window is not a free pass.
Prioritize anti-inflammatory foods: fatty fish (salmon, sardines, mackerel), leafy greens, colorful vegetables, extra virgin olive oil, and legumes if tolerated. An AIP or Mediterranean base provides the strongest anti-inflammatory foundation during eating hours.
Ultra-processed foods in the eating window undermine the inflammatory benefits of the fasting window. This is not theoretical: studies that combine IF with dietary quality improvement show larger and more durable effects than IF alone.
Step 5: Monitor and Adjust
Track three things: daily energy levels, a symptom diary, and inflammatory markers (CRP at baseline and 90-day retest).
Signs IF is not working for you: worsening fatigue within two weeks, increased brain fog, a symptom flare within 30 days, or significant mood deterioration. These are signals to shorten your fasting window or stop entirely.
For Hashimoto's patients: recheck TSH and Free T3 at 90 days. Some patients show thyroid hormone changes on aggressive IF that are not apparent from symptoms alone.
When NOT to Fast: Safety and Contraindications
This section exists because fasting content online rarely addresses who should avoid it. For autoimmune patients, the contraindication list is longer than for the general population.
Absolute contraindications:
- Active disease flare (RA, lupus, IBD, or any other autoimmune condition). Fasting during a flare adds physiological stress without benefit.
- BMI below 18.5 or recent unintended weight loss. Autoimmune patients frequently have malabsorption; fasting compounds it.
- Adrenal insufficiency (primary or secondary). Fasting requires cortisol mobilization. Insufficient adrenal reserve raises the risk of adrenal crisis.
- History of eating disorder. Time-restricted eating can reactivate disordered eating patterns.
- Pregnancy or breastfeeding.
- Active cancer treatment.
- Type 1 diabetes. Fasting with insulin therapy carries hypoglycemia risk requiring medical management.
- Children and adolescents under 18.
Discuss with your physician first:
- Hashimoto's with low Free T3: impaired metabolic adaptation to fasting.
- High-dose corticosteroids (prednisone above 10 mg/day): glucose instability during fasting.
- Methotrexate: increased nausea risk when fasting.
- Low ferritin or B12 (common in celiac and IBD): fasting may worsen existing deficiencies.
Frequently Asked Questions
Is intermittent fasting safe with autoimmune disease?
For many people, yes, with appropriate precautions. 16:8 time-restricted eating is the lowest-risk entry point. The key is starting gradually (12:12 first), monitoring symptoms, and recognizing contraindications. Active flares, low BMI, adrenal insufficiency, and Type 1 diabetes are absolute contraindications. Discuss IF with your physician before starting, particularly if you take immunosuppressants or corticosteroids.
Which autoimmune condition benefits most from intermittent fasting?
Rheumatoid arthritis has the strongest human evidence, primarily from Ramadan fasting studies showing reduced DAS-28 scores and inflammatory markers during the fasting month. Psoriasis also shows good evidence, particularly in overweight patients where fasting reduces the visceral fat driving IL-17 production. For MS, the fasting mimicking diet has stronger support than standard IF protocols.
Can Hashimoto's patients do intermittent fasting?
With caution. HPA axis dysregulation and low T3 are common in Hashimoto's, and both impair metabolic adaptation to fasting. Start with 12:12 (circadian-aligned eating) rather than 16:8. Monitor energy and brain fog closely. Recheck TSH and Free T3 after 90 days. If symptoms worsen, 14:10 may be your ceiling. Selenium and myo-inositol have stronger Hashimoto's-specific evidence than fasting.
Does fasting reduce autoimmune antibodies (like TPO antibodies)?
No direct evidence supports this. Fasting reduces general inflammatory markers (CRP, IL-6, TNF-alpha), which may indirectly dampen the inflammatory environment that sustains antibody production. But for TPO antibody reduction specifically, selenium supplementation has far stronger evidence than any fasting protocol.
What is the difference between intermittent fasting and the fasting mimicking diet?
IF restricts when you eat (time-based). FMD restricts what and how much you eat over five consecutive days (700 to 1,100 kcal/day, plant-based, low protein, specific macros). FMD was designed to trigger deeper fasting biology (immune cell recycling, stem cell activation, mTOR suppression) while still providing calories. FMD has stronger evidence for autoimmune-relevant immune reset. The full FMD guide covers protocol details, the Crohn's RCT, and contraindications.
Can I fast during a lupus or RA flare?
No. Fasting during an active flare adds physiological stress when your body needs resources for healing. Wait until remission or low disease activity. During a flare, prioritize anti-inflammatory nutrition and physician-directed treatment. IF is an adjunct for stable disease, not a crisis intervention.
How long does it take to see results from intermittent fasting with autoimmune disease?
Inflammatory marker changes (CRP, IL-6) are detectable within four to eight weeks in most studies. Subjective symptom improvement, if it occurs, is reported within four to twelve weeks. Joint stiffness and pain in RA patients improved during Ramadan (a roughly four-week protocol). Gut microbiome remodeling requires consistent practice over eight to twelve weeks. Do not expect changes in the first week or two.
Find your personalized protocol. Intermittent fasting is one tool in the autoimmune toolkit. Your condition, severity, medications, and metabolic status determine whether IF belongs in your protocol and which type fits best. Take the free 3-minute AutoimmuneFinder quiz to get an evidence-graded protocol matched to your specific situation.
This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting intermittent fasting or changing your treatment plan, especially if you take immunosuppressants, corticosteroids, or thyroid medication.